MAIA - Maia Biotechnology, Inc.

Insider Purchase by Louie Ngar Yee (Dir)

3 Months
After Trade
Before Trade

Loading data...

Trade Summary

2 months ago, Louie Ngar Yee, serving as Dir at Maia Biotechnology, Inc. (MAIA), purchased 81,699 shares at $1.22 per share, for a total transaction value of $100,000.00. Following this transaction, Louie Ngar Yee now holds 1,248,888 shares of MAIA.

This purchase represents a 7.00% increase in Louie Ngar Yee's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, December 22, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, December 23, 2025, 1 day after the trade was made.

Maia Biotechnology, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Louie Ngar Yee

Dir

Adelina Louie Ngar Yee is an independent director at MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, particularly ateganosine (THIO) for non-small cell lung cancer.[[2]](https://ir.maiabiotech.com/news-events/press-releases/detail/165/maia-biotechnology-board-members-continue-to-participate-in)[[4]](https://maiabiotech.com/about/board-of-directors/) She serves as Chair of the Nominating and Corporate Governance Committee.[[9]](https://ir.maiabiotech.com/corporate-governance/board-committees) Ms. Louie has demonstrated strong confidence in MAIA by making significant investments, including purchasing 81,699 shares at $1.224 on December 22, 2025, increasing her direct ownership to 1,248,888 shares, along with stock options, and participating in private placements.[[1]](https://www.investing.com/news/insider-trading-news/louie-ngar-yee-buys-maia-biotechnology-maia-shares-worth-99999-93CH-4421152)[[2]](https://ir.maiabiotech.com/news-events/press-releases/detail/165/maia-biotechnology-board-members-continue-to-participate-in)[[5]](https://www.stocktitan.net/sec-filings/MAIA/form-4-maia-biotechnology-inc-insider-trading-activity-51b542498fec.html) Ms. Louie brings over 30 years of experience with the HSBC Group, primarily in Global Banking and Markets, including investment and securities management, asset management, global research, and leadership in Group Internal Audit across Latin America, Asia Pacific, and the UK.[[4]](https://maiabiotech.com/about/board-of-directors/) Born and educated in Hong Kong, she joined HSBC as an executive trainee, became an International Manager in 1996, and held key roles in Hong Kong, the Philippines, Indonesia, Taiwan, the US, UK, and Latin America, driving business re-engineering, turnarounds, and setups.[[4]](https://maiabiotech.com/about/board-of-directors/) Prior to joining MAIA's board in April 2020, she served as Group Chief Operating Officer of Group Internal Audit at HSBC.[[4]](https://maiabiotech.com/about/board-of-directors/)

View full insider profile →

Trade Price

$1.22

Quantity

81,699

Total Value

$100,000.00

Shares Owned

1,248,888

Trade Date

Monday, December 22, 2025

62 days ago

SEC Filing Date

Tuesday, December 23, 2025

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Maia Biotechnology, Inc.

Company Overview

No company information available
View news mentioning MAIA

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/2470376

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime